At the time of writing, Mirum Pharmaceuticals Inc [MIRM] stock is trading at $71.81, up 0.41%. An important factor to consider is whether the stock is rising or falling in short-term value. The MIRM shares have gain 7.69% over the last week, with a monthly amount glided 38.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On April 17, 2024, Stifel initiated with a Buy rating and assigned a price target of $48 on the stock. H.C. Wainwright reiterated its Buy rating and decreased its price target to $58 on December 18, 2023. Morgan Stanley started tracking with a Overweight rating for this stock on November 13, 2023, and assigned it a price target of $60. In a note dated October 24, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $50 on this stock.
For the past year, the stock price of Mirum Pharmaceuticals Inc fluctuated between $36.86 and $72.08. Currently, Wall Street analysts expect the stock to reach $85 within the next 12 months. Mirum Pharmaceuticals Inc [NASDAQ: MIRM] shares were valued at $71.81 at the most recent close of the market. An investor can expect a potential return of 18.37% based on the average MIRM price forecast.
Analyzing the MIRM fundamentals
According to Mirum Pharmaceuticals Inc [NASDAQ:MIRM], the company’s sales were 429.16M for trailing twelve months, which represents an 64.09% jump. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.13%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.25 and Total Capital is -0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.07 points at the first support level, and at 70.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 72.28, and for the 2nd resistance point, it is at 72.74.
Ratios To Look Out For
It is important to note that Mirum Pharmaceuticals Inc [NASDAQ:MIRM] has a current ratio of 3.13. On the other hand, the Quick Ratio is 2.97, and the Cash Ratio is 1.58. Considering the valuation of this stock, the price to sales ratio is 8.41, the price to book ratio is 14.09.
Transactions by insiders
Recent insider trading involved Peetz Christopher, CHIEF EXECUTIVE OFFICER, that happened on Aug 11 ’25 when 40000.0 shares were sold. Officer, CHRISTOPHER PEETZ completed a deal on Aug 11 ’25 to buy 40000.0 shares. Meanwhile, SVP, GLOBAL CONTROLLER Howe Jolanda sold 10000.0 shares on Aug 07 ’25.
